PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -5.6% | 4,404 | +3.6% | 0.00% | 0.0% |
| Q2 2022 | $248,000 | -23.5% | 4,250 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $324,000 | -27.8% | 4,245 | -43.1% | 0.00% | 0.0% |
| Q4 2021 | $449,000 | +12.2% | 7,454 | +4.4% | 0.00% | -33.3% |
| Q3 2021 | $400,000 | +22.0% | 7,142 | +32.1% | 0.00% | +50.0% |
| Q2 2021 | $328,000 | +3.1% | 5,407 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $318,000 | -16.3% | 4,540 | -28.5% | 0.00% | -50.0% |
| Q4 2020 | $380,000 | +21.0% | 6,352 | +21.7% | 0.00% | 0.0% |
| Q3 2020 | $314,000 | +30.8% | 5,219 | +14.0% | 0.00% | +33.3% |
| Q2 2020 | $240,000 | +8.1% | 4,577 | -6.7% | 0.00% | 0.0% |
| Q4 2019 | $222,000 | -32.9% | 4,908 | -43.6% | 0.00% | -40.0% |
| Q3 2019 | $331,000 | +32.4% | 8,702 | +51.3% | 0.01% | +25.0% |
| Q2 2019 | $250,000 | -47.1% | 5,751 | +7.9% | 0.00% | -96.3% |
| Q4 2014 | $473,000 | – | 5,331 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |